Previous 10 | Next 10 |
VBI Vaccines Inc. (NASDAQ: VBIV) (VBI or the Company), a biopharmaceutical company driven by immunology in the pursuit of powerful prevention and treatment of disease, today announced that the underwriters of its recent underwritten public offering of common shares and accompanying common warrant...
PreHevbri ® is the only approved 3-antigen hepatitis B vaccine for adults in the Netherlands and Belgium Product to be launched via marketing and distribution partner, Valneva VBI Vaccines Inc. (Nasdaq: VBIV) (VBI), a biopharmaceutical company driven by immunology in the pu...
2023-07-07 08:29:03 ET Prestige Wealth ( PWM ) +106% . Gorilla Technology Group ( GRRR ) +74% Signs Contract to Deploy Massive Smart Government Project in Egypt. NuZee ( NUZE ) +51% Secures Five-Year Global Licensing Deal with Stone Brewing to...
2023-07-06 13:08:25 ET Gainers: EdtechX Holdings Acquisition ( EDTX ) +40% . Mullen Automotive ( MULN ) +35% . Genius Sports Limited ( GENI ) +21% . Incannex Healthcare Limited ( IXHL ) +19% . Sweetgreen ( SG ) +18% . urban-g...
2023-07-06 09:59:32 ET Shares of VBI Vaccines ( NASDAQ: VBIV ) tumbled 51.7% to $1.17 on Thursday after pricing its underwritten public offering and concurrent registered direct offering to cumulatively raise $21 million. The company priced the public offering of 10,...
Approximately $21 million in gross proceeds from underwritten public offering and concurrent registered direct offering add to upfront payment from Brii Biosciences for a combined $33 million to be received by VBI VBI Vaccines Inc. ( NASDAQ: VBIV ) (VBI or the Company), a biopharmac...
2023-07-06 08:32:06 ET Allarity Therapeutics ALLR -53% after pricing public offering to $11M ASLAN Pharmaceuticals Limited ( ASLN ) -33% to host webcast on July 6, 2023, to discuss phase 2b topline data from TREK-AD trial evaluating Eblasakimab in atopic dermatitis. ...
2023-07-05 17:35:55 ET VBI Vaccines ( NASDAQ: VBIV ) is down ~3% in after-hours trading Wednesday after it announced an underwritten public offering and a registered direct offering of common shares and warrants. Raymond James is the sole book-runner. VBI ( ...
VBI Vaccines Inc. ( NASDAQ: VBIV ) (“VBI” or the “Company”), a biopharmaceutical company driven by immunology in the pursuit of powerful prevention and treatment of disease, today announced that it has commenced an underwritten public offering and a registered dire...
Brii Biosciences has acquired worldwide exclusive license to VBI-2601 and an exclusive license for PreHevbri® in the Asia Pacific region VBI will receive gross proceeds of $15 million in upfront payments, subject to near-term milestone achievements, including an equity investment of appr...
News, Short Squeeze, Breakout and More Instantly...
PreHevbrio ® (Hepatitis B Vaccine [Recombinant]) global net revenue increased 234% year-over-year from 2022 to 2023 Preliminary 2024 PreHevbrio U.S. sales demonstrate continued growth, with approximately 65% of 2023 full-year volume sold in Q1 2024 alone Early data from randomize...
Shares of Fastenal Company (NASDAQ: FAST) fell sharply during Thursday’s session following worse-than-expected first-quarter financial resul...